Mutations in the human SRSF2 gene altering its RNA-binding affinity impairs hematopoietic differentiation in vivo and is frequently (40% incidence) found in patients with myelodysplastic syndromes and certain leukaemias28,58,59. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.